Mycosis Fungoides/Sézary Syndrome: A Report of Three Cases Treated with Campath-1H as Salvage Treatment

Reporting results of cancer treatment

1981 • 7,916 citations

Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy

1987 • 1,177 citations

Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

2001 • 685 citations

Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.

1979 • 548 citations

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.

1997 • 531 citations

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome

2003 • 390 citations

Primary Cutaneous T-Cell Lymphoma: Review and Current Concepts

2000 • 311 citations

Mycosis fungoides and Sezary syndrome [see comments]

1996 • 284 citations

Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary Syndrome

1988 • 270 citations

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

1998 • 264 citations

Systemic Therapy of Cutaneous T-Cell Lymphomas (Mycosis Fungoides and the Sezary Syndrome)

1994 • 214 citations

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.

1997 • 210 citations

Prognostic signs and the management of the mycosis fungoides

1973 • 183 citations

Prognostic factor analysis in mycosis fungoides/Sézary syndrome

1999 • 173 citations

Mycosis fungoides and the Sézary syndrome: Pathology, staging, and treatment

1990 • 130 citations

Prognostic factors in Sézary syndrome: A multivariate analysis of clinical, haematological and immunological features

1998 • 117 citations

Clinical Characteristics and Outcome of Patients With Extracutaneous Mycosis Fungoides

2001 • 112 citations

Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

1994 • 93 citations

Prognostic variables in mycosis fungoides

1981 • 82 citations

Alemtuzumab in T-Cell Malignancies

2002 • 66 citations

Combination of Etoposide, Idarubicin, Cyclophosphamide, Vincristine, Prednisone and Bleomycin (VICOP-B) in the Treatment of Advanced Cutaneous T-Cell Lymphoma

1997 • 38 citations

Prognosis and Staging of Cutaneous T-cell Lymphoma

1995 • 34 citations

INTRAMUSCULAR LOW DOSE ALPHA‐2B INTERFERON AND ETRETINATE FOR TREATMENT OF MYCOSIS FUNGOIDES

1993 • 29 citations

ADVANCES IN THE MANAGEMENT OF CUTANEOUS T-CELL LYMPHOMA

1998 • 16 citations